SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    C. V. Almario, M. Vega, S. B. Trooskin, V. J. Navarro, Examining hepatitis c virus testing practices in primary care clinics, Journal of Viral Hepatitis, 2012, 19, 2
  2. 2
    Susanna Naggie, Mark S. Sulkowski, Management of Patients Coinfected With HCV and HIV: A Close Look at the Role for Direct-Acting Antivirals, Gastroenterology, 2012, 142, 6, 1324

    CrossRef

  3. 3
    Hui-Ying Rao, De-Gui Sun, Rui-Feng Yang, Feng Liu, Jian Wang, Bo Feng, Nan Wu, Ji-Lian Fang, Guang-Jun Song, Hui Ma, Fang Guo, Jiang-Hua Wang, Xiao-Bo Li, Qian Jin, Hong Qin, Hui Zhuang, Lai Wei, Outcome of hepatitis C virus infection in Chinese paid plasma donors: A 12–19-year cohort study, Journal of Gastroenterology and Hepatology, 2012, 27, 3
  4. 4
    Jinah Choi, Oxidative stress, endogenous antioxidants, alcohol, and hepatitis C: pathogenic interactions and therapeutic considerations, Free Radical Biology and Medicine, 2012, 52, 7, 1135

    CrossRef

  5. 5
    Christopher D. Anderson, Jeffrey S. Crippin, Blumgart's Surgery of the Liver, Pancreas and Biliary Tract, 2012,

    CrossRef

  6. 6
    Rae Jean Proeschold-Bell, Ashwin A. Patkar, Susanna Naggie, Lesleyjill Coward, Paolo Mannelli, Jia Yao, Patricia Bixby, Andrew J. Muir, An Integrated Alcohol Abuse and Medical Treatment Model for Patients with Hepatitis C, Digestive Diseases and Sciences, 2011, 57, 4, 1083

    CrossRef

  7. 7
    Clinical Guidelines for the Diagnosis and Treatment of HIV/AIDS in HIV-infected Koreans, Infection and Chemotherapy, 2011, 43, 2, 89

    CrossRef

  8. 8
    Maria Ripoli, Valerio Pazienza, Impact of HCV genetic differences on pathobiology of disease, Expert Review of Anti-infective Therapy, 2011, 9, 9, 747

    CrossRef

  9. 9
    Daniel Fuster, Jordi Tor, Celestino Rey-Joly, Robert Muga, Interacciones patogénicas entre alcohol y hepatitis C, Medicina Clínica, 2011,

    CrossRef

  10. 10
    Onpan Cheung, Richard K. Sterling, Jennifer Salvatori, Kim Williams, Sarah Hubbard, Velimir A. Luketic, Todd R. Stravitz, Arun J. Sanyal, Melissa J. Contos, Scott Mills, Mitchell L. Shiffman, Mild Alcohol Consumption is Not Associated With Increased Fibrosis in Patients With Chronic Hepatitis C, Journal of Clinical Gastroenterology, 2011, 45, 1, 76

    CrossRef

  11. 11
    Andrew M. Miller, Norio Horiguchi, Won-IL Jeong, Svetlana Radaeva, Bin Gao, Molecular Mechanisms of Alcoholic Liver Disease: Innate Immunity and Cytokines, Alcoholism: Clinical and Experimental Research, 2011, 35, 5
  12. 12
    Friedrich M. Wurst, Natasha Thon, Michel Yegles, Claudia Halter, Wolfgang Weinmann, Barbara Laskowska, Johannes Strasser, Gregory Skipper, Gerhard A. Wiesbeck, Kenneth Dürsteler-MacFarland, Optimizing heroin-assisted treatment (HAT): Assessment of the contribution of direct ethanol metabolites in identifying hazardous and harmful alcohol use, Drug and Alcohol Dependence, 2011, 115, 1-2, 57

    CrossRef

  13. 13
    Hirokazu Takahashi, Toshihiko Mizuta, Yuichiro Eguchi, Yasunori Kawaguchi, Takuya Kuwashiro, Satoshi Oeda, Hiroshi Isoda, Noriko Oza, Shinji Iwane, Kenichi Izumi, Keizou Anzai, Iwata Ozaki, Kazuma Fujimoto, Post-challenge hyperglycemia is a significant risk factor for the development of hepatocellular carcinoma in patients with chronic hepatitis C, Journal of Gastroenterology, 2011, 46, 6, 790

    CrossRef

  14. 14
    Eric R. Kallwitz, Ethnic and Racial Differences in the Natural History of Hepatitis C, Current Hepatitis Reports, 2010, 9, 2, 106

    CrossRef

  15. 15
    Eric R. Kallwitz, Jennifer Layden–Almer, Manish Dhamija, Jamie Berkes, Grace Guzman, Rita Lepe, Scott J. Cotler, Thomas J. Layden, Ethnicity and Body Mass Index Are Associated With Hepatitis C Presentation and Progression, Clinical Gastroenterology and Hepatology, 2010, 8, 1, 72

    CrossRef

  16. 16
    Ayman A. Koteish, Hepatitis C Plus Alcohol or Marijuana: Which Is Worse?, Current Hepatitis Reports, 2010, 9, 1, 20

    CrossRef

  17. 17
    János Fehér, Gabriella Lengyel, Hepatocellularis carcinoma: előfordulás, kórokok, biomarkerek, Orvosi Hetilap, 2010, 151, 23, 933

    CrossRef

  18. 18
    E. Delarocque-Astagneau, C. Meffre, F. Dubois, C. Pioche, Y. Le Strat, F. Roudot-Thoraval, P. Hillon, C. Silvain, D. Dhumeaux, J. -C. Desenclos, The impact of the prevention programme of hepatitis C over more than a decade: the French experience, Journal of Viral Hepatitis, 2010, 17, 6
  19. 19
    Eser Kırkızlar, Daniel M. Faissol, Paul M. Griffin, Julie L. Swann, Timing of testing and treatment for asymptomatic diseases, Mathematical Biosciences, 2010, 226, 1, 28

    CrossRef

  20. 20
    Gavin H. Harris, Shiela M. Strauss, Carina Katigbak, Bhupinder S. Brar, Lawrence S. Brown, Steven S. Kipnis, Steven A. Kritz, Mark W. Parrino, Variation among state-level approaches to addressing alcohol abuse in opioid treatment programs, Journal of Substance Abuse Treatment, 2010, 39, 1, 58

    CrossRef

  21. 21
    S. Gitto, L. Micco, F. Conti, P. Andreone, M. Bernardi, Alcohol and viral hepatitis: A mini-review, Digestive and Liver Disease, 2009, 41, 1, 67

    CrossRef

  22. 22
    Audrey H. Lau, Gyongyi Szabo, Angus W. Thomson, Antigen-presenting cells under the influence of alcohol, Trends in Immunology, 2009, 30, 1, 13

    CrossRef

  23. 23
    Marc G. Ghany, Doris B. Strader, David L. Thomas, Leonard B. Seeff, Diagnosis, management, and treatment of hepatitis C: An update, Hepatology, 2009, 49, 4
  24. 24
    Gudrun Høiseth, Luca Morini, Aldo Polettini, Asbjørg Christophersen, Jørg Mørland, Ethyl Glucuronide in Hair Compared With Traditional Alcohol Biomarkers—A Pilot Study of Heavy Drinkers Referred to an Alcohol Detoxification Unit, Alcoholism: Clinical and Experimental Research, 2009, 33, 5
  25. 25
    Shirley X. Hu, Namgyal L. Kyulo, Victor W. Xia, Donald J. Hillebrand, Ke-Qin Hu, Factors Associated With Hepatic Fibrosis In Patients With Chronic Hepatitis C, Journal of Clinical Gastroenterology, 2009, 43, 8, 758

    CrossRef

  26. You have free access to this content26
    M. C. Andrade, M. J. S. Albernaz, M. S. S. Araújo, B. P. Santos, A. Teixeira-Carvalho, A. M. C. Faria, O. A. Martins-Filho, Short-term Administration of Ethanol in Mice Deviates Antigen Presentation Activity Towards B Cells, Scandinavian Journal of Immunology, 2009, 70, 3
  27. 27
    Sam Galhenage, Manal F. Abdelmalek, The impact of steatosis and alcohol on hepatitis C, Current Hepatitis Reports, 2009, 6, 2, 39

    CrossRef

  28. 28
    H. PATEL, E. J. HEATHCOTE, When to treat and the benefits of treating hepatitis C in patients with haemophilia, Haemophilia, 2009, 15, 1
  29. 29
    Jean-Philippe Lang, Laurent Michel, Michel Burger, Faredj Cherikh, Jean-Marie Lang, Michel Doffoel, Psychiatrie, VIH et hépatite C, 2009,

    CrossRef

  30. 30
    Paul Strock, Joël Mossong, Karine Hawotte, Vic Arendt, Access to Treatment of Hepatitis C in Prison Inmates, Digestive Diseases and Sciences, 2008, 54, 6, 1325

    CrossRef

  31. 31
    Friedrich Martin Wurst, Kenneth M. Dürsteler-MacFarland, Volker Auwaerter, Sonja Ergovic, Natasha Thon, Michel Yegles, Claudia Halter, Wolfgang Weinmann, Gerhard A. Wiesbeck, Assessment of Alcohol Use Among Methadone Maintenance Patients by Direct Ethanol Metabolites and Self-Reports, Alcoholism: Clinical and Experimental Research, 2008, 32, 9
  32. 32
    C.-H. Hung, C.-H. Chen, C.-M. Lee, C.-M. Wu, T.-H. Hu, J.-H. Wang, Y.-H. Yen, S.-N. Lu, Association of amino acid variations in the NS5A and E2-PePHD region of hepatitis C virus 1b with hepatocellular carcinoma, Journal of Viral Hepatitis, 2008, 15, 1
  33. 33
    Brian Wells Pence, Nathan M. Thielman, Kathryn Whetten, Jan Ostermann, Virender Kumar, Michael J. Mugavero, Coping Strategies and Patterns of Alcohol and Drug Use among HIV-Infected Patients in the United States Southeast, AIDS Patient Care and STDs, 2008, 22, 11, 869

    CrossRef

  34. 34
    David M. Novick, Mary Jeanne Kreek, Critical issues in the treatment of hepatitis C virus infection in methadone maintenance patients, Addiction, 2008, 103, 6
  35. 35
    Sharif B. Missiha, Mario Ostrowski, E. Jenny Heathcote, Disease Progression in Chronic Hepatitis C: Modifiable and Nonmodifiable Factors, Gastroenterology, 2008, 134, 6, 1699

    CrossRef

  36. 36
    Giovan Giuseppe Di Costanzo, Massimo De Luca, Giovanni Tritto, Filippo Lampasi, Luigi Addario, Alfonso Galeota Lanza, Maria Teresa Tartaglione, Francesco Paolo Picciotto, Antonio Ascione, Effect of alcohol, cigarette smoking, and diabetes on occurrence of hepatocellular carcinoma in patients with transfusion-acquired hepatitis C virus infection who develop cirrhosis, European Journal of Gastroenterology & Hepatology, 2008, 20, 7, 674

    CrossRef

  37. 37
    Ariane Mallat, Christophe Hezode, Sophie Lotersztajn, Environmental factors as disease accelerators during chronic hepatitis C, Journal of Hepatology, 2008, 48, 4, 657

    CrossRef

  38. 38
    Christoph H. Österreicher, Juliane Halangk, Thomas Berg, Eleonora Patsenker, Nils Homann, Claus Hellerbrand, Helmut K. Seitz, Dennis Eurich, Felix Stickel, Evaluation of the transforming growth factor β1 codon 25 (Arg→Pro) polymorphism in alcoholic liver disease, Cytokine, 2008, 42, 1, 18

    CrossRef

  39. 39
    Ian Homer Y. Cua, Jason M. Hui, James G. Kench, Jacob George, Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C, Hepatology, 2008, 48, 3
  40. 40
    Sylvie Deuffic-Burban, Pierre Deltenre, Alexandre Louvet, Valérie Canva, Sebastien Dharancy, Antoine Hollebecque, Jeanne Boitard, Jean Henrion, Yazdan Yazdanpanah, Philippe Mathurin, Impact of viral eradication on mortality related to hepatitis C: A modeling approach in France, Journal of Hepatology, 2008, 49, 2, 175

    CrossRef

  41. 41
    Suzanne Norris, Diarmaid Houlihan, Liver transplantation in HIV-positive patients, Expert Review of Gastroenterology & Hepatology, 2008, 2, 1, 39

    CrossRef

  42. 42
    Karsten Wursthorn, Michael P. Manns, Heiner Wedemeyer, Natural history: The importance of viral load, liver damage and HCC, Best Practice & Research Clinical Gastroenterology, 2008, 22, 6, 1063

    CrossRef

  43. 43
    Carol Mallette, Maura A Flynn, Kittichai Promrat, Outcome of Screening for Hepatitis C Virus Infection Based on Risk Factors, The American Journal of Gastroenterology, 2008, 103, 1, 131

    CrossRef

  44. 44
    K. Trujillo-Murillo, O. Álvarez-Martínez, L. Garza-Rodríguez, H. Martínez-Rodríguez, F. Bosques-Padilla, J. Ramos-Jiménez, H. Barrera-Saldaña, A. R. Rincón-Sánchez, A. M. Rivas-Estilla, Additive effect of ethanol and HCV subgenomic replicon expression on COX-2 protein levels and activity, Journal of Viral Hepatitis, 2007, 14, 9
  45. You have free access to this content45
    Chiung M. Chen, Young-Hee Yoon, Hsiao-ye Yi, Diane L. Lucas, Alcohol and Hepatitis C Mortality Among Males and Females in the United States: A Life Table Analysis, Alcoholism: Clinical and Experimental Research, 2007, 31, 2
  46. 46
    Helmut K. Seitz, Felix Stickel, Alcoholic Liver Disease in the Elderly, Clinics in Geriatric Medicine, 2007, 23, 4, 905

    CrossRef

  47. 47
    Costica Aloman, Stephan Gehring, Philip Wintermeyer, Noriyoshi Kuzushita, Jack R. Wands, Chronic Ethanol Consumption Impairs Cellular Immune Responses Against HCV NS5 Protein Due to Dendritic Cell Dysfunction, Gastroenterology, 2007, 132, 2, 698

    CrossRef

  48. 48
    H. E. Harris, K. P. Eldridge, S. Harbour, G. Alexander, C.-G. Teo, M. E. Ramsay, Does the clinical outcome of hepatitis C infection vary with the infecting hepatitis C virus type?, Journal of Viral Hepatitis, 2007, 14, 3
  49. 49
    Yuki Kita, Eishiro Mizukoshi, Toshinari Takamura, Masaru Sakurai, Yoshiko Takata, Kuniaki Arai, Tatsuya Yamashita, Yasunari Nakamoto, Shuichi Kaneko, Impact of diabetes mellitus on prognosis of patients infected with hepatitis C virus, Metabolism, 2007, 56, 12, 1682

    CrossRef

  50. 50
    Ashwani K. Singal, Bhupinder S. Anand, Mechanisms of Synergy Between Alcohol and Hepatitis C Virus, Journal of Clinical Gastroenterology, 2007, 41, 8, 761

    CrossRef

  51. 51
    Geoffrey C. Nguyen, Dorry L. Segev, Paul J. Thuluvath, Nationwide Increase in Hospitalizations and Hepatitis C Among Inpatients With Cirrhosis and Sequelae of Portal Hypertension, Clinical Gastroenterology and Hepatology, 2007, 5, 9, 1092

    CrossRef

  52. 52
    Ahmad Kamal, Ramsey Cheung, Positive CAGE Screen Correlates with Cirrhosis in Veterans with Chronic Hepatitis C, Digestive Diseases and Sciences, 2007, 52, 10, 2564

    CrossRef

  53. 53
    Scott Seronello, Muhammad Y. Sheikh, Jinah Choi, Redox regulation of hepatitis C in nonalcoholic and alcoholic liver, Free Radical Biology and Medicine, 2007, 43, 6, 869

    CrossRef

  54. 54
    Z. Kayali, S. Tan, L. Shinkunas, M. Voigt, D. R. LaBrecque, J. T. Stapleton, K. E. Brown, W. N. Schmidt, Risk factors for hepatitis C fibrosis: a prospective study of United States veterans compared with nonveterans, Journal of Viral Hepatitis, 2007, 14, 1
  55. 55
    Spilios Manolakopoulos, Michalis Economou, Sotirios Bethanis, Nicoletta Mathou, Christos Triantos, Jiannis Vlachogiannakos, Evangelos Vogiatzakis, Alec Avgerinos, Dimitrios Tzourmakliotis, A single alcohol ingestion does not affect serum hepatitis C virus RNA in patients with chronic hepatitis C, Liver International, 2006, 26, 10
  56. 56
    Bhupinder S. Anand, Sue Currie, Eric Dieperink, Edmund J. Bini, Hui Shen, Samuel B. Ho, Teresa Wright, Alcohol Use and Treatment of Hepatitis C Virus: Results of a National Multicenter Study, Gastroenterology, 2006, 130, 6, 1607

    CrossRef

  57. 57
    Amrita Sethi, Mitchell L. Shiffman, Approach to the Management of Patients with Chronic Hepatitis C Who Failed to Achieve Sustained Virologic Response, Infectious Disease Clinics of North America, 2006, 20, 1, 115

    CrossRef

  58. 58
    Fulton T. Crews, Rabih Bechara, Lou Ann Brown, David M. Guidot, Pranoti Mandrekar, Shilpa Oak, Liya Qin, Gyongyi Szabo, Michael Wheeler, Jian Zou, Cytokines and Alcohol, Alcoholism: Clinical and Experimental Research, 2006, 30, 4
  59. 59
    Ting Zhang, Yuan Li, Wen-Zhe Ho, Drug abuse, innate immunity and hepatitis C virus, Reviews in Medical Virology, 2006, 16, 5
  60. 60
    Marc G. Ghany, Leonard B. Seeff, Efforts to Define the Natural History of Chronic Hepatitis C Continue, Clinical Gastroenterology and Hepatology, 2006, 4, 10, 1190

    CrossRef

  61. 61
    Michael J. Sweeting, Daniela De Angelis, Keith R. Neal, Mary E. Ramsay, William L. Irving, Mark Wright, Lisa Brant, Helen E. Harris, Estimated progression rates in three United Kingdom hepatitis C cohorts differed according to method of recruitment, Journal of Clinical Epidemiology, 2006, 59, 2, 144

    CrossRef

  62. 62
    Jordan J. Feld, T. Jake Liang, Hepatitis C — identifying patients with progressive liver injury, Hepatology, 2006, 43, S1
  63. 63
    Jennifer V. Campbell, Holly Hagan, Mary H. Latka, Richard S. Garfein, Elizabeth T. Golub, Micaela H. Coady, David L. Thomas, Steffanie A. Strathdee, High prevalence of alcohol use among hepatitis C virus antibody positive injection drug users in three US cities, Drug and Alcohol Dependence, 2006, 81, 3, 259

    CrossRef

  64. 64
    Velimir Kostic, Maja Jovanovic, Ljiljana Konstantinovic, Emina Kostic, Vesna Mihailovic, Liver damage caused by hepatitis C viral infection and ethyl alcohol consumption, Vojnosanitetski pregled, 2006, 63, 4, 393

    CrossRef

  65. 65
    M. Carrière, A. R. Rosenberg, F. Conti, S. Chouzenoux, B. Terris, P. Sogni, O. Soubrane, Y. Calmus, P. Podevin, Low density lipoprotein receptor transcripts correlates with liver hepatitis C virus RNA in patients with alcohol consumption, Journal of Viral Hepatitis, 2006, 13, 9
  66. 66
    Julien Massard, Vlad Ratziu, Dominique Thabut, Joseph Moussalli, Pascal Lebray, Yves Benhamou, Thierry Poynard, Natural history and predictors of disease severity in chronic hepatitis C, Journal of Hepatology, 2006, 44, S19

    CrossRef

  67. 67
    Anaïs Vallet-Pichard, Stanislas Pol, Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection, Journal of Hepatology, 2006, 44, S28

    CrossRef

  68. 68
    Maribel Rodr??guez-Torres, Carlos F. R??os-Bedoya, Jos?? Rodr??guez-Orengo, Alberto Fern??ndez-Carbia, Acisclo M. Marxuach-Cu??tara, Abimael L??pez-Torres, Rosa Salgado-Mercado, Norbert Br??u, Progression to Cirrhosis in Latinos With Chronic Hepatitis C: Differences in Puerto Ricans With and Without Human Immunodeficiency Virus Coinfection and Along Gender, Journal of Clinical Gastroenterology, 2006, 40, 4, 358

    CrossRef

  69. 69
    Sandra Tuma Khouri, Renata M. Perez, Patr??cia Marinho de Oliveira, Virginia Maria Figueiredo, Denize Vieira Barbosa, Valeria Pereira Lanzoni, Antonio Eduardo B. Silva, Maria Lucia Ferraz, Rebiopsy in Patients With Untreated Hepatitis C: A Useful Procedure, Journal of Clinical Gastroenterology, 2006, 40, 4, 347

    CrossRef

  70. 70
    Matthew L Cowan, James D Maxwell, Treatment of hepatitis C virus infection in intravenous drug users, Acta Neuropsychiatrica, 2006, 18, 5
  71. 71
    M. Mazen Jamal, Zainab Saadi, Timothy R. Morgan, Alcohol and Hepatitis C, Digestive Diseases, 2005, 23, 3-4, 285

    CrossRef

  72. 72
    Michael D. Voigt, Alcohol in Hepatocellular Cancer, Clinics in Liver Disease, 2005, 9, 1, 151

    CrossRef

  73. 73
    Amrita Sethi, Mitchell L. Shiffman, Approach to the Management of Patients with Chronic Hepatitis C Who Failed to Achieve Sustained Virologic Response, Clinics in Liver Disease, 2005, 9, 3, 453

    CrossRef

  74. 74
    Adeel A Butt, Hepatitis C virus infection: the new global epidemic, Expert Review of Anti-infective Therapy, 2005, 3, 2, 241

    CrossRef

  75. 75
    Izumi Hasegawa, Etsuro Orito, Yasuhito Tanaka, Noboru Hirashima, Kenji Sakakibara, Mayumi Sakurai, Seiji Suzuki, Fuminaka Sugauchi, Tomoyoshi Ohno, Ryuzo Ueda, Masashi Mizokami, Impact of occult hepatitis B virus infection on efficacy and prognosis of interferon-α therapy for patients with chronic hepatitis C, Liver International, 2005, 25, 2
  76. 76
    Sharon J. Hutchinson, Sheila M. Bird, David J. Goldberg, Influence of Alcohol on the Progression of Hepatitis C Virus Infection: A Meta-analysis, Clinical Gastroenterology and Hepatology, 2005, 3, 11, 1150

    CrossRef

  77. 77
    Mark L Willenbring, Integrating care for patients with infectious, psychiatric, and substance use disorders: concepts and approaches, AIDS, 2005, 19, Suppl 3, S227

    CrossRef

  78. 78
    Joy C. Draper, Elinore F. McCance-Katz, Medical Illness and Comorbidities in Drug Users: Implications for Addiction Pharmacotherapy Treatment, Substance Use & Misuse, 2005, 40, 13-14, 1899

    CrossRef

  79. 79
    Chuan-Qing Wang, Yuan Li, Steven D. Douglas, Xu Wang, David S. Metzger, Ting Zhang, Wen-Zhe Ho, Morphine Withdrawal Enhances Hepatitis C Virus Replicon Expression, The American Journal of Pathology, 2005, 167, 5, 1333

    CrossRef

  80. 80
    J. D. Collier, T. Woodall, D. G. D. Wight, S. Shore, A. E. Gimson, G. J. M. Alexander, Predicting progressive hepatic fibrosis stage on subsequent liver biopsy in chronic hepatitis C virus infection, Journal of Viral Hepatitis, 2005, 12, 1
  81. 81
    J. J. Goedert, Prevalence of conditions associated with human immunodeficiency and hepatitis virus infections among persons with haemophilia, 2001–2003, Haemophilia, 2005, 11, 5
  82. 82
    Robert M. Weinrieb, Michael R. Lucey, Transplantation of the Liver, 2005,

    CrossRef

  83. 83
    Dawn Sears, Gary L. Davis, Transplantation of the Liver, 2005,

    CrossRef

  84. 84
    Lorna M. Dove, A general approach to the management of chronic hepatitis C, Gastroenterology Clinics of North America, 2004, 33, 3, 463

    CrossRef

  85. 85
    Martina Burger, Anja Brönstrup, Klaus Pietrzik, Derivation of tolerable upper alcohol intake levels in Germany: a systematic review of risks and benefits of moderate alcohol consumption, Preventive Medicine, 2004, 39, 1, 111

    CrossRef

  86. 86
    Doris B. Strader, Teresa Wright, David L. Thomas, Leonard B. Seeff, Diagnosis, management, and treatment of hepatitis C, Hepatology, 2004, 39, 4
  87. 87
    K. B. Anderson, J. L. Guest, D. Rimland, Hepatitis C Virus Coinfection Increases Mortality in HIV-Infected Patients in the Highly Active Antiretroviral Therapy Era: Data from the HIV Atlanta VA Cohort Study, Clinical Infectious Diseases, 2004, 39, 10, 1507

    CrossRef

  88. 88
    Anaı̈s Vallet-Pichard, Stanislas Pol, Hepatitis viruses and human immunodeficiency virus co-infection: pathogenisis and treatment, Journal of Hepatology, 2004, 41, 1, 156

    CrossRef

  89. 89
    S. Pol, P. Lebra, A. Vallet-Pichard, HIV Infection and Hepatic Enzyme Abnormalities: Intricacies of the Pathogenic Mechanisms, Clinical Infectious Diseases, 2004, 38, Supplement 2, S65

    CrossRef

  90. 90
    J. J. Goedert, D. L. Brown, K. Hoots, K. E. Sherman, Human immunodeficiency and hepatitis virus infections and their associated conditions and treatments among people with haemophilia, Haemophilia, 2004, 10,
  91. 91
    Archana Sud, Jason M. Hui, Geoffrey C. Farrell, Priyanka Bandara, James G. Kench, Carolyn Fung, Rita Lin, Dev Samarasinghe, Christopher Liddle, Geoffrey W. McCaughan, Jacob George, Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index, Hepatology, 2004, 39, 5
  92. 92
    Giuseppe Mastrangelo, Ugo Fedeli, Emanuela Fadda, Flavio Valentini, Roberto Agnesi, Giancarlo Magarotto, Teresio Marchì, Andrea Buda, Massimo Pinzani, Diego Martines, Increased Risk of Hepatocellular Carcinoma and Liver Cirrhosis in Vinyl Chloride Workers: Synergistic Effect of Occupational Exposure with Alcohol Intake, Environmental Health Perspectives, 2004, 112, 11, 1188

    CrossRef

  93. 93
    Barbara A. Piasecki, James D. Lewis, K. Rajender Reddy, Scarlett L. Bellamy, Steven B. Porter, Robert M. Weinrieb, Donald D. Stieritz, Kyong-Mi Chang, Influence of alcohol use, race, and viral coinfections on spontaneous HCV clearance in a US veteran population, Hepatology, 2004, 40, 4
  94. 94
    Barbara A. Piasecki, James D. Lewis, K. Rajender Reddy, Scarlett L. Bellamy, Steven B. Porter, Robert M. Weinrieb, Donald D. Stieritz, Kyong-Mi Chang, Influence of alcohol use, race, and viral coinfections on spontaneous HCV clearance in a US veteran population, Hepatology, 2004, 40, 4, 892

    CrossRef

  95. 95
    Natalie Stieltjes, Nadra Ounnoughene, Emilie Sava, Patricia Paugy, Valérie Roussel-Robert, Arielle R. Rosenberg, Benoit Terris, Dominique Salmon-Céron, Philippe Sogni, Interest of transjugular liver biopsy in adult patients with haemophilia or other congenital bleeding disorders infected with hepatitis C virus, British Journal of Haematology, 2004, 125, 6
  96. 96
    Maxime Cournot, André Glibert, Fabienne Castel, François Druart, Kamran Imani, Valérie Lauwers-Cances, Thierry Morin, Management of hepatitis C in active drugs users: experience of an addiction care hepatology unit, Gastroentérologie Clinique et Biologique, 2004, 28, 6-7, 533

    CrossRef

  97. 97
    Lorraine Gunzerath, Vivian Faden, Samir Zakhari, Kenneth Warren, National Institute on Alcohol Abuse and Alcoholism Report on Moderate Drinking, Alcoholism: Clinical and Experimental Research, 2004, 28, 6
  98. 98
    Alexander Monto, Keyur Patel, Alan Bostrom, Stephen Pianko, Paul Pockros, John G. McHutchison, Teresa L. Wright, Risks of a range of alcohol intake on hepatitis C-related fibrosis, Hepatology, 2004, 39, 3
  99. 99
    W. Ray Kim, John J. Poterucha, Joanne T. Benson, Terry M. Therneau, The impact of competing risks on the observed rate of chronic hepatitis C progression, Gastroenterology, 2004, 127, 3, 749

    CrossRef

  100. 100
    Marcus Mühlbauer, Anja K Bosserhoff, Arndt Hartmann, Wolfgang E Thasler, Thomas S Weiss, Hans Herfarth, Guntram Lock, Jürgen Schölmerich, Claus Hellerbrand, A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease, Gastroenterology, 2003, 125, 4, 1085

    CrossRef

  101. 101
    Angela Dolganiuc, Karen Kodys, Andrea Kopasz, Christopher Marshall, Pranoti Mandrekar, Gyongyi Szabo, Additive Inhibition of Dendritic Cell Allostimulatory Capacity by Alcohol and Hepatitis C Is Not Restored by DC Maturation and Involves Abnormal IL-10 and IL-2 Induction, Alcoholism: Clinical & Experimental Research, 2003, 27, 6, 1023

    CrossRef

  102. 102
    Angela Dolganiuc, Karen Kodys, Andrea Kopasz, Christopher Marshall, Pranoti Mandrekar, Gyongyi Szabo, Additive Inhibition of Dendritic Cell Allostimulatory Capacity by Alcohol and Hepatitis C Is Not Restored by DC Maturation and Involves Abnormal IL-10 and IL-2 Induction, Alcoholism: Clinical and Experimental Research, 2003, 27, 6
  103. 103
    Gabriel Perlemuter, Philippe Lettéron, Françoise Carnot, Flora Zavala, Dominique Pessayre, Bertrand Nalpas, Christian Bréchot, Alcohol and hepatitis C virus core protein additively increase lipid peroxidation and synergistically trigger hepatic cytokine expression in a transgenic mouse model, Journal of Hepatology, 2003, 39, 6, 1020

    CrossRef

  104. 104
    Alexander Monto, Alcohol and hepatitis C: Implications for disease progression and treatment, Current Hepatitis Reports, 2003, 2, 3, 125

    CrossRef

  105. 105
    Miguel A. Serra, Amparo Escudero, Felicidad Rodríguez, Juan A. del Olmo, José M. Rodrigo, Effect of Hepatitis C Virus Infection and Abstinence From Alcohol on Survival in Patients With Alcoholic Cirrhosis, Journal of Clinical Gastroenterology, 2003, 36, 2, 170

    CrossRef

  106. 106
    Charles S. Lieber, Hepatitis C and Alcohol, Journal of Clinical Gastroenterology, 2003, 36, 2, 100

    CrossRef

  107. 107
    Renuka Bhattacharya, Margaret C. Shuhart, Hepatitis C and Alcohol, Journal of Clinical Gastroenterology, 2003, 36, 3, 242

    CrossRef

  108. 108
    Timothy R. Morgan, David Brenner, James Everhart, Samuel W. French, Michael W. Fried, David R. Gretch, Margaret James Koziel, Craig J. McClain, Marion G. Peters, Steven A. Weinman, Diane L. Lucas, Hepatitis C and Alcohol: Fundamental and Translational Research Directions, Alcoholism: Clinical & Experimental Research, 2003, 27, 4, 726

    CrossRef

  109. 109
    Timothy R. Morgan, David Brenner, James Everhart, Samuel W. French, Michael W. Fried, David R. Gretch, Margaret James Koziel, Craig J. McClain, Marion G. Peters, Steven A. Weinman, Diane L. Lucas, Hepatitis C and Alcohol: Fundamental and Translational Research Directions, Alcoholism: Clinical and Experimental Research, 2003, 27, 4
  110. 110
    Helen S. Yee, Teresa L. Wright, Hepatitis C antiviral treatment in special populations, Current Hepatitis Reports, 2003, 2, 3, 101

    CrossRef

  111. 111
    Oluwatoyin M. Falusi, Joseph Pulvirenti, Julia Sarazine, Priya Shastri, Cheri Gail, Robert Glowacki, HIV-Infected Inpatients in the HAART Era: How Do Hepatitis C Virus CoInfected Patients Differ?, AIDS Patient Care and STDs, 2003, 17, 1, 13

    CrossRef

  112. 112
    C. HÉzode, I. Lonjon, F. Roudot-Thoraval, J.-M. Pawlotsky, E.-S. Zafrani, D. Dhumeaux, Impact of moderate alcohol consumption on histological activity and fibrosis in patients with chronic hepatitis C, and specific influence of steatosis: a prospective study, Alimentary Pharmacology & Therapeutics, 2003, 17, 8
  113. 113
    M.Mazen Jamal, Timothy R Morgan, Liver disease in alcohol and hepatitis C, Best Practice & Research Clinical Gastroenterology, 2003, 17, 4, 649

    CrossRef

  114. 114
    Patricia E. Molina, Jan B. Hoek, Steve Nelson, David M. Guidot, Charles H. Lang, Jack R. Wands, James M. Crawford, Mechanisms of Alcohol-Induced Tissue Injury, Alcoholism: Clinical and Experimental Research, 2003, 27, 3
  115. 115
    Yuan Li, Ting Zhang, Steven D. Douglas, Jian-Ping Lai, Wei-Dong Xiao, David E. Pleasure, Wen-Zhe Ho, Morphine Enhances Hepatitis C Virus (HCV) Replicon Expression, The American Journal of Pathology, 2003, 163, 3, 1167

    CrossRef

  116. 116
    Gyongyi Szabo, Pathogenic interactions between alcohol and hepatitis C, Current Gastroenterology Reports, 2003, 5, 1, 86

    CrossRef

  117. 117
    A. J. Freeman, M. G. Law, J. M. Kaldor, G. J. Dore, Predicting progression to cirrhosis in chronic hepatitis C virus infection, Journal of Viral Hepatitis, 2003, 10, 4
  118. 118
    Jean-Pierre Zarski, John Mc Hutchison, Jean-Pierre Bronowicki, Nathalie Sturm, Richard Garcia-Kennedy, Enkelejda Hodaj, Brenda Truta, Teresa Wright, Robert Gish, Rate of natural disease progression in patients with chronic hepatitis C, Journal of Hepatology, 2003, 38, 3, 307

    CrossRef

  119. 119
    Thierry Poynard, Man-Fung Yuen, Vlad Ratzin, Ching Lung Lai, Viral hepatitis C, The Lancet, 2003, 362, 9401, 2095

    CrossRef

  120. 120
    Andrew J. Muir, Dawn Provenzale, A Descriptive Evaluation of Eligibility for Therapy Among Veterans With Chronic Hepatitis C Virus Infection, Journal of Clinical Gastroenterology, 2002, 34, 3, 268

    CrossRef

  121. 121
    Marion G. Peters, Norah A. Terrault, Alcohol use and hepatitis C, Hepatology, 2002, 36, S1
  122. 122
    Sandro Vento, Francesca Cainelli, Does hepatitis C virus cause severe liver disease only in people who drink alcohol?, The Lancet Infectious Diseases, 2002, 2, 5, 303

    CrossRef

  123. 123
    Patrick Marcellin, Tarik Asselah, Nathalie Boyer, Fibrosis and disease progression in hepatitis C, Hepatology, 2002, 36, S1
  124. 124
    Brent D Lemberg, Thomas A Shaw-Stiffel, Hepatic disease in injection drug users, Infectious Disease Clinics of North America, 2002, 16, 3, 667

    CrossRef

  125. 125
    Tak-Mao CHAN, Hepatitis C virus infection in patients on renal replacement therapy, Hong Kong Journal of Nephrology, 2002, 4, 1, 3

    CrossRef

  126. 126
    Hisayuki Hamada, Hiroshi Yatsuhashi, Koji Yano, Manabu Daikoku, Kokichi Arisawa, Osami Inoue, Michiaki Koga, Keisuke Nakata, Katsumi Eguchi, Michitami Yano, Impact of aging on the development of hepatocellular carcinoma in patients with posttransfusion chronic hepatitis C, Cancer, 2002, 95, 2
  127. 127
    Bin Gao, Interaction of alcohol and hepatitis viral proteins, Alcohol, 2002, 27, 1, 69

    CrossRef

  128. 128
    Gregory J Dore, Anthony J Freeman, Matthew Law, JohnM Kaldor, Is severe liver disease a common outcome for people with chronic hepatitisC?, Journal of Gastroenterology and Hepatology, 2002, 17, 4
  129. 129
    Caroline A. Sabin, Vince Emery, Helen L. Devereux, Anja Griffioen, Jeremy Bishop, Geoff Dusheiko, Thynn Thynn Yee, Esteban Herrero-Martinez, Christine A. Lee, Long-term patterns of hepatitis C virus RNA concentrations in a cohort of HIV seronegative men with bleeding disorders, Journal of Medical Virology, 2002, 68, 1
  130. 130
    J. Westin, L. M. Lagging, F. Spak, N. Aires, E. Svensson, M. Lindh, A. P. Dhillon, G. Norkrans, R. Wejstål, Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection, Journal of Viral Hepatitis, 2002, 9, 3
  131. 131
    Geoffrey M. Thiele, Gyongyi Szabo, Elizabeth J. Kovacs, Abraham P. Bautista, Laura Sosa, Thomas R. Jerrells, Modulation of Immunity and Viral-Host Interactions by Alcohol, Alcoholism: Clinical & Experimental Research, 2002, 26, 12, 1897

    CrossRef

  132. 132
    Geoffrey M. Thiele, Gyongyi Szabo, Elizabeth J. Kovacs, Abraham P. Bautista, Laura Sosa, Thomas R. Jerrells, Modulation of Immunity and Viral-Host Interactions by Alcohol, Alcoholism: Clinical and Experimental Research, 2002, 26, 12
  133. 133
    Leonard B. Seeff, Natural history of chronic hepatitis C, Hepatology, 2002, 36, S1
  134. 134
    P. Cacoub, Y. Benhamou, Place des interférons dans le traitement des infections par les virusde l'hépatite B et de l'hépatite C, La Revue de Médecine Interne, 2002, 23, 459S

    CrossRef

  135. 135
    Markus Sagmeister, Eberhard L. Renner, Beat Mullhaupt, John B. Wong, Simulation of hepatitis C based on a mandatory reporting system, European Journal of Gastroenterology & Hepatology, 2002, 14, 1, 25

    CrossRef

  136. 136
    Raymond S. Koff, Disease Management Programs for Hepatitis C, Disease Management and Health Outcomes, 2001, 9, 8, 431

    CrossRef

  137. 137
    S. Pianko, S. Patella, G. Ostapowicz, P. Desmond, W. Sievert, Fas-mediated hepatocyte apoptosis is increased by hepatitis C virus infection and alcohol consumption, and may be associated with hepatic fibrosis: mechanisms of liver cell injury in chronic hepatitis C virus infection, Journal of Viral Hepatitis, 2001, 8, 6
  138. 138
    Gyongyi Szabo, Donna Catalano, Gary Bellerose, Pranoti Mandrekar, Interferon ?? and Alcohol Augment Nuclear Regulatory Factor-??B Activation in HepG2 Cells, and Interferon ?? Increases Pro-Inflammatory Cytokine Production, Alcoholism: Clinical and Experimental Research, 2001, 25, 8, 1188

    CrossRef

  139. 139
    Gyongyi Szabo, Donna Catalano, Gary Bellerose, Pranoti Mandrekar, Interferon α and Alcohol Augment Nuclear Regulatory Factor-κB Activation in HepG2 Cells, and Interferon α Increases Pro-Inflammatory Cytokine Production, Alcoholism: Clinical and Experimental Research, 2001, 25, 8
  140. 140
    Francesca Cainelli, Ercole Concia, Sandro Vento, Mortality Due to Hepatitis C Virus–Related Cirrhosis in Patients Infected with HIV Type 1: A Role for Alcohol, Clinical Infectious Diseases, 2001, 33, 10, 1795

    CrossRef

  141. 141
    Huy A. Nguyen, Samuel B. Ho, Natural history of chronic hepatitis C: Identifying a window of opportunity for intervention, Disease-a-Month, 2001, 47, 12, 593

    CrossRef

  142. 142
    Gyongyi Szabo, Pranoti Mandrekar, Angela Dolganiuc, Donna Catalano, Karen Kodys, Reduced Alloreactive T-Cell Activation After Alcohol Intake is Due to Impaired Monocyte Accessory Cell Function and Correlates With Elevated IL-10, IL-13, and Decreased IFN?? Levels, Alcoholism: Clinical and Experimental Research, 2001, 25, 12, 1766

    CrossRef

  143. 143
    Gyongyi Szabo, Pranoti Mandrekar, Angela Dolganiuc, Donna Catalano, Karen Kodys, Reduced Alloreactive T-Cell Activation After Alcohol Intake is Due to Impaired Monocyte Accessory Cell Function and Correlates With Elevated IL-10, IL-13, and Decreased IFNγ Levels, Alcoholism: Clinical and Experimental Research, 2001, 25, 12
  144. 144
    George V. Papatheodoridis, Susan Davies, Amar P. Dhillon, Rosangela Teixeira, John Goulis, Brian Davidson, Keith Rolles, Geoffrey Dusheiko, Andrew K. Burroughs, THE ROLE OF DIFFERENT IMMUNOSUPPRESSION IN THE LONG-TERM HISTOLOGICAL OUTCOME OF HCV REINFECTION AFTER LIVER TRANSPLANTATION FOR HCV CIRRHOSIS, Transplantation, 2001, 72, 3, 412

    CrossRef

  145. 145
    Gary L. Davis, James R. Rodrigue, Treatment of Chronic Hepatitis C in Active Drug Users, New England Journal of Medicine, 2001, 345, 3, 215

    CrossRef

  146. 146
    H Inoue, H K Seitz, Viruses and alcohol in the pathogenesis of primary hepatic carcinoma, European Journal of Cancer Prevention, 2001, 10, 1, 107

    CrossRef

  147. 147
    Arturo Pereira, Cristina Sanz, A model of the health and economic impact of posttransfusion hepatitis C: application to cost-effectiveness analysis of further expansion of HCV screening protocols, Transfusion, 2000, 40, 10
  148. 148
    Stephen Pianko, Shane Patella, William Sievert, Alcohol consumption induces hepatocyte apoptosis in patients with chronic hepatitis C infection, Journal of Gastroenterology and Hepatology, 2000, 15, 7
  149. 149
    Willis C. Maddrey, ALCOHOL-INDUCED LIVER DISEASE, Clinics in Liver Disease, 2000, 4, 1, 115

    CrossRef

  150. 150
    Charles S. Lieber, Alcoholic liver disease: New insights in pathogenesis lead to new treatments, Journal of Hepatology, 2000, 32, 113

    CrossRef

  151. 151
    Leslie Isaki, Thomas F. Kresina, Directions for Biomedical Research in Alcohol and HIV: Where Are We Now and Where Can We Go?, AIDS Research and Human Retroviruses, 2000, 16, 13, 1197

    CrossRef

  152. 152
    Estimating future hepatitis C morbidity, mortality, and costs in the United States, American Journal of Public Health, 2000, 90, 10, 1562

    CrossRef

  153. 153
    J. Encke, J. R. Wands, Ethanol Inhibition: The Humoral and Cellular Immune Response to Hepatitis C Virus NS5 Protein After Genetic Immunization, Alcoholism: Clinical and Experimental Research, 2000, 24, 7, 1063

    CrossRef

  154. 154
    J. Encke, J.R. Wands, Ethanol Inhibition: The Humoral and Cellular Immune Response to Hepatitis C Virus NS5 Protein After Genetic Immunization, Alcoholism: Clinical and Experimental Research, 2000, 24, 7
  155. 155
    Mark S. Sulkowski, Eric E. Mast, Leonard B. Seeff, David L. Thomas, Hepatitis C Virus Infection as an Opportunistic Disease in Persons Infected with Human Immunodeficiency Virus, Clinical Infectious Diseases, 2000, 30, s1, S77

    CrossRef

  156. 156
    Timothy Gayowski, Nina Singh, Lois Keyes, Cheryl F. Wannstedt, Marilyn M. Wagener, Hugo Vargas, Tomacz Laskus, Jorge Rakela, John J. Fung, Ignazio R. Marino, LATE-ONSET RENAL FAILURE AFTER LIVER TRANSPLANTATION: ROLE OF POSTTRANSPLANT ALCOHOL USE1, Transplantation, 2000, 69, 3, 383

    CrossRef

  157. 157
    Hiroshi Yatsuhashi, Michitami Yano, Natural history of chronic hepatitis C, Journal of Gastroenterology and Hepatology, 2000, 15,
  158. 158
    Thierry Poynard, Vlad Ratziu, Yves Benhamou, Pierre Opolon, Patrice Cacoub, Pierre Bedossa, Natural history of HCV infection, Best Practice & Research Clinical Gastroenterology, 2000, 14, 2, 211

    CrossRef

  159. 159
    Nathalie Boyer, Patrick Marcellin, Pathogenesis, diagnosis and management of hepatitis C, Journal of Hepatology, 2000, 32, 98

    CrossRef

  160. 160
    Kamal G. Ishak, MD, PhD, Pathologic Features of Chronic Hepatitis, American Journal of Clinical Pathology, 2000, 113, 1, 40

    CrossRef

  161. 161
    Arie Regev, Eugene R. Schiff, VIRAL HEPATITIS A, B, AND C, Clinics in Liver Disease, 2000, 4, 1, 47

    CrossRef

  162. 162
    Mahbub H. Khan, Geoffrey C. Farrell, Karen Byth, Rita Lin, Martin Weltman, Jacob George, Dev Samarasinghe, James Kench, Songal Kaba, Evelyn Crewe, Chris Liddle, Which patients with hepatitis C develop liver complications?, Hepatology, 2000, 31, 2
  163. 163
    Jean-Pierre Zarski, Vincent Leroy, Counselling patients with hepatitis C, Journal of Hepatology, 1999, 31, 136

    CrossRef

  164. 164
    F. Blaine Hollinger, FACTORS CONTRIBUTING TO THE EVOLUTION AND OUTCOME OF CIRRHOSIS IN HEPATITIS C, Clinics in Liver Disease, 1999, 3, 4, 741

    CrossRef

  165. 165
    Françoise Degos, Hepatitis C and alcohol, Journal of Hepatology, 1999, 31, 113

    CrossRef

  166. 166
    Arie Regev, Lennox J. Jeffers, Hepatitis C and Alcohol, Alcoholism: Clinical and Experimental Research, 1999, 23, 9
  167. 167
    Richard H. Moseley, Hepatology, Current Opinion in Gastroenterology, 1999, 15, 3, 181

    CrossRef

  168. 168
    Eugene R Schiff, The alcoholic patient with Hepatitis C Virus infection, The American Journal of Medicine, 1999, 107, 6, 95

    CrossRef

  169. 169
    G. Y. Minuk, The influence of host factors on the natural history of chronic hepatitis C viral infections, Journal of Viral Hepatitis, 1999, 6, 4
    Direct Link:
  170. 170
    Arie Regev, Eugene R. Schiff, Viral hepatitis, Current Opinion in Gastroenterology, 1999, 15, 3, 234

    CrossRef

  171. 171
    Leonard B. Seeff, The natural history of hepatitis C—A quandary, Hepatology, 1998, 28, 6
  172. 172
    A Rambaldi, C Gluud, Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis, The Cochrane Library,
  173. 173
    Andrea Rambaldi, Christian Gluud, Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis, The Cochrane Library,